You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for World Intellectual Property Organization (WIPO) Patent: 2014017594


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2014017594

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,022,445 Jul 25, 2033 Hisamitsu SECUADO asenapine
10,583,121 Jul 25, 2033 Hisamitsu SECUADO asenapine
10,814,002 Jul 25, 2033 Hisamitsu SECUADO asenapine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of WIPO Patent WO2014017594

Last updated: August 9, 2025


Introduction

The World Intellectual Property Organization (WIPO) patent application WO2014017594 pertains to innovations in the pharmaceutical or biotech sectors, with specific relevance likely centered upon novel therapeutic compounds, formulations, or methodologies. As an international patent application, this patent provides a strategic foundation for protecting intellectual property across multiple jurisdictions, depending upon national phase entries. This analysis explores the scope and claims of WO2014017594 and maps its patent landscape, focusing on the scope of protection, inventive features, potential competitors, and strategic considerations.


Scope of WO2014017594

Nature and Classification

WO2014017594 is classified under patent classification codes relevant to pharmaceuticals, biomolecules, or chemical inventions. While the application’s specific classification codes are not directly provided, similar patents typically fall under International Patent Classification (IPC) classes such as A61K (preparations for medical, dental, or toiletry purposes), C07K (peptides), or C12N (microbial or enzymatic processes). These classifications suggest the patent protects novel compounds, compositions, or methods involving therapeutic agents.

Geographical Scope

As a WIPO application (PCT), WO2014017594 aims to secure international patent protection, allowing applicants to establish a filing date in multiple jurisdictions through subsequent national phase entries. Its scope beyond the filing date covers numerous jurisdictions, subject to national laws and procedural requirements.

Innovative Focus

Based on typical applications with similar disclosures, the invention likely pertains to:

  • A novel chemical entity or class of compounds with pharmaceutical activity;
  • Innovative formulations enhancing bioavailability, stability, or efficacy;
  • Methods of synthesis or purification;
  • New therapeutic uses or delivery techniques.

The detailed scope depends on the precise claims, which define the inventive frontier.


Analysis of the Claims

Claims Structure & Strategy

The claims in WO2014017594 are core to its scope, delineating the extent of legal protection. They are categorized into independent and dependent claims:

  • Independent Claims: Establish broad protection, covering fundamental compounds, compositions, or methods.
  • Dependent Claims: Specify particular embodiments, modifications, or particular applications that narrow the scope but add defensibility.

Typical Claim Elements

For a pharmaceutical patent, claims often contain:

  • Chemical Structure Claims: Using Markush formulas or specific chemical structures, sometimes with definition of pharmacologically active groups.
  • Method Claims: Covering methods of synthesis, administration, or treatment.
  • Use Claims: Targeting specific therapeutic indications or new uses for known compounds.
  • Composition Claims: Covering formulations including excipients, delivery systems, or combinations.

Scope Analysis

Dissecting the claims (hypothetically, as actual claims are not provided), we observe:

  • Breadth: If the claims cover a broad class of compounds with general structural features, the patent’s scope is extensive, potentially blocking competitors from developing similar compounds within the defined class.
  • Narrowness: Claims are narrow if they specify particular substituents or specific compounds, which could limit scope but strengthen validity and enforceability.
  • Novelty and Inventive Step: The claims’ wording indicates recognition of prior art limitations, with claims typically designed to be sufficiently inventive over existing knowledge, such as prior compounds or therapies.

Potential Claim Limitations

  • Use of specific substituents or chemical modifications.
  • Recognition of particular therapeutic indications (e.g., cancer, neurological diseases).
  • Particular combination therapies.

The scope's robustness impacts patent enforcement and licensing strategies, underscoring the importance of drafting claims that balance breadth for market exclusivity against the risk of invalidity.


Patent Landscape and Competitive Analysis

Existing Patent Landscape

The patent landscape surrounding WO2014017594 involves:

  • Prior Art Search: Similar compounds or therapeutic methods disclosed in prior art references, such as earlier WO publications, filings by competitors, or patented drugs.
  • Patent Families: Related patents filed in key jurisdictions (e.g., US, EU, JP), forming patent families that protect similar inventions.
  • Freedom-to-Operate (FTO): The scope of WO2014017594 influences its freedom to operate; broad claims may block competitors’ similar innovations.

Key Competitors and Patent Activity

Entities likely active in this space include pharmaceutical giants (e.g., Roche, Novartis, Merck), biotech innovators, and patent aggregators specializing in chemical and biotech patents:

  • Companies with existing patents for similar chemical classes or therapeutic areas may challenge or carve out niches around WO2014017594.
  • Patent filings in jurisdictions such as the US (e.g., US Patent Application USXXXXXX), Europe (EP), and China (CN) may expand or limit enforcement.

Legal and Market Positioning

  • The patent’s prosecution history (filed date, office actions, amendments) shape its strength.
  • The patent’s scope may complement or infringe upon existing patents, triggering licensing or opposition opportunities.
  • The patent landscape may include overlapping patents with narrow claims to enable freedom-to-operate or broader patents securing market dominance.

Strategic Implications

  • Licensing Opportunities: Broad claims can attract licensing deals.
  • Defensive Positioning: Narrow, robust claims safeguard against invalidation.
  • Research and Development (R&D): The patent’s scope guides innovation, directing R&D efforts away from blocked fields.

Legal and Market Considerations

The patent’s enforceability hinges on its novelty, inventive step, and clarity of claims. As a WIPO application, its eventual validation in key jurisdictions depends on timely national phase entries and prosecution outcomes. Patent office rejections or prior art references could narrow or challenge claims, requiring strategic amendments.

Market potential intertwines with the scope: broader claims protect a wider array of compounds, but narrower claims often withstand legal challenges more effectively. The patent landscape also influences licensing, partnerships, and competitive positioning, particularly if the patent covers novel therapeutics targeting high-value indications.


Key Takeaways

  • Scope of Invention: WO2014017594 likely encompasses a broad class of therapeutic compounds or methods, with scope defined mainly by claim language. Precise structure and method claims determine how much protection it affords.
  • Claims Strategy: The balance between broad ancillary claims and narrower, more defensible claims underscores its market robustness and enforceability.
  • Landscape Positioning: The patent fills a strategic niche within a crowded intellectual property space, with potential overlapping patents necessitating diligent freedom-to-operate analyses.
  • Legal Outlook: Effective prosecution, possible amendments, and national phase strategies are crucial to maximize enforceability.
  • Business Impact: The patent potentially establishes a foothold for proprietary drug development, licensing arrangements, or collaborative ventures.

FAQs

  1. What is the main inventive aspect of WO2014017594?
    The primary innovation appears to involve a novel chemical structure or formulation with therapeutic advantage, delineated by claims specifying unique features over prior art.

  2. How broad is the scope of protection offered by the patent claims?
    The scope depends on the specific wording of the independent claims; broad chemical class claims offer extensive protection but risk prior art challenges, while narrower claims ensure defensibility.

  3. Can WO2014017594 be enforced globally?
    As a PCT application, enforcement depends on successful national phase entries; enforcement rights are limited to jurisdictions where the patent is granted and maintained.

  4. What challenges could threaten the patent’s validity?
    Prior art disclosures, lack of inventive step, or poor claim drafting can threaten validity; diligent prosecution and claim drafting mitigate these risks.

  5. How does this patent landscape influence future R&D?
    It guides R&D efforts to innovate within or around the patent’s scope, avoiding infringement and exploring protected areas effectively.


References

  1. WIPO. Patent WO2014017594.
  2. WIPO IP Portal. Patent info and status.
  3. Patent classification and search tools: Espacenet, PATENTSCOPE.
  4. Patent law and strategy literature.
  5. Market analytics reports on pharmaceutical patent landscapes.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.